Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive Localizers

[1]  M. Morrow,et al.  Correction to: Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? , 2020, Annals of Surgical Oncology.

[2]  Barbara L. Smith,et al.  Radiofrequency identification tag localization is comparable to wire localization for non-palpable breast lesions , 2019, Breast Cancer Research and Treatment.

[3]  W. Barry,et al.  Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy , 2019, Annals of Surgical Oncology.

[4]  Heather I. Greenwood,et al.  Feasibility of Magnetic Seeds for Preoperative Localization of Axillary Lymph Nodes in Breast Cancer Treatment. , 2019, AJR. American journal of roentgenology.

[5]  F. Wärnberg,et al.  A combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgery. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  A. Kusske,et al.  Microchipping the breast: an effective new technology for localizing non-palpable breast lesions for surgery , 2019, Breast Cancer Research and Treatment.

[7]  Sadia Choudhery,et al.  Tomosynthesis-Guided Needle Localization of Breast and Axillary Lesions: Our Initial Experience. , 2019, AJR. American journal of roentgenology.

[8]  B. Taback,et al.  Enhanced Axillary Evaluation Using Reflector‐Guided Sentinel Lymph Node Biopsy: A Prospective Feasibility Study and Comparison With Conventional Lymphatic Mapping Techniques , 2018, Clinical breast cancer.

[9]  M. Specht,et al.  Evaluation of a Nonradioactive Magnetic Marker Wireless Localization Program. , 2018, AJR. American journal of roentgenology.

[10]  V. Peg,et al.  Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) , 2018, Annals of Surgical Oncology.

[11]  Julie Morris,et al.  Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study , 2018, Breast Cancer Research and Treatment.

[12]  L. Esserman,et al.  Initial Clinical Experience With an Inducible Magnetic Seed System for Preoperative Breast Lesion Localization. , 2018, AJR. American journal of roentgenology.

[13]  J. Boughey,et al.  Localizing the Clipped Node in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Early Learning Experience and Challenges , 2017, Annals of Surgical Oncology.

[14]  H. Kuerer,et al.  Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  F. Schnabel,et al.  A Prospective, Single Arm, Multi-site, Clinical Evaluation of a Nonradioactive Surgical Guidance Technology for the Location of Nonpalpable Breast Lesions during Excision , 2016, Annals of Surgical Oncology.

[16]  S. Mclaughlin,et al.  Symptomatic Axillary Seroma after Sentinel Lymph Node Biopsy: Incidence and Treatment , 2016, Annals of Surgical Oncology.

[17]  G. Plitas,et al.  How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study , 2016, Annals of Surgical Oncology.

[18]  K. Hunt,et al.  Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0–T4, N1–N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance) , 2016, Annals of surgery.

[19]  A. Soran,et al.  Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes , 2016, Annals of Surgical Oncology.

[20]  Murray A Reicher,et al.  A prospective clinical study to evaluate the safety and performance of wireless localization of nonpalpable breast lesions using radiofrequency identification technology. , 2015, AJR. American journal of roentgenology.

[21]  D. Plecha,et al.  Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph Nodes , 2015, Annals of Surgical Oncology.

[22]  H. Kuerer,et al.  Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial. , 2015, JAMA surgery.

[23]  E. Rutgers,et al.  Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. , 2015, Annals of surgery.

[24]  M. Brackstone,et al.  Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Gideon Blumenthal,et al.  Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis , 2014, The Lancet.

[26]  S. Mclaughlin,et al.  Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. , 2013, JAMA.

[27]  T. Fehm,et al.  Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. , 2013, The Lancet. Oncology.

[28]  H. Kuerer,et al.  The Role for Sentinel Lymph Node Dissection after Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast Cancer , 2012, Annals of Surgical Oncology.

[29]  Chiu-Hsieh Hsu,et al.  Intraoperative Touch Imprint and Frozen Section Analysis of Sentinel Lymph Nodes After Neoadjuvant Chemotherapy for Breast Cancer , 2010, Annals of surgery.

[30]  Murray A Reicher,et al.  Radiofrequency identification tags for preoperative tumor localization: proof of concept. , 2008, AJR. American journal of roentgenology.

[31]  Kelly K Hunt,et al.  Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Sheryl G. A. Gabram,et al.  Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial , 2006, Annals of Surgical Oncology.

[33]  Ralph T. Wynn,et al.  Reflector-guided breast tumor localization versus wire localization for lumpectomies: A comparison of surgical outcomes. , 2018, Clinical imaging.